U.S. Stock News

NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

Is It Time To Reconsider Verra Mobility (VRRM) After A 39.7% One Year Share Price Fall

Wondering whether Verra Mobility stock is starting to look appealing at its current price, especially after a tough run? This article focuses squarely on what that price might really imply about value. The stock last closed at US$14.63 and has returned 0.5% over 30 days, yet year to date it is down 34.5% and the 1 year return is a 39.7% decline, which can change how investors think about both risk and opportunity. Recent coverage has focused on how the stock's weaker 1 year and 3 year...
NasdaqCM:SERV
NasdaqCM:SERVHospitality

Serve Robotics (SERV) Posts US$34 Million Quarterly Loss Challenging Bullish Growth Narratives

Serve Robotics (SERV) has posted FY 2025 results that highlight a small but growing top line alongside sizable losses, with Q4 revenue at about US$0.9 million and a quarterly net loss of roughly US$34.3 million, or EPS of US$0.46 loss, while trailing 12 month revenue sits at roughly US$2.7 million against a net loss of about US$101.4 million and EPS of US$1.63 loss. Over recent quarters the company has seen revenue move from around US$0.18 million in Q4 FY 2024 to US$0.88 million in Q4 FY...
NYSE:TAP
NYSE:TAPBeverage

A Look At Molson Coors (TAP) Valuation After Its Latest Quarterly Earnings Update

Molson Coors Beverage (TAP) stock is reacting to fresh quarterly results, with first quarter sales of US$2,717.9 million and net income of US$151.3 million, along with a regular US$0.48 per share dividend declaration. See our latest analysis for Molson Coors Beverage. The first quarter update has come against a weak backdrop for the stock, with a 90 day share price return of a 16.67% decline and a 1 year total shareholder return of a 17.34% loss, so recent momentum has been fading despite...
NasdaqCM:AKBA
NasdaqCM:AKBABiotechs

Akebia Therapeutics (AKBA) Is Down 14.5% After Swing To Q1 Loss And Share Increase Plan

Akebia Therapeutics, Inc. has reported past first-quarter 2026 results showing revenue of US$53.54 million versus US$57.34 million a year earlier, with net loss of US$9.05 million replacing prior net income of US$6.11 million. A recent proposal to increase authorized capital stock to 525,000,000 shares, including 500,000,000 common shares, adds a potential dilution and financing angle to Akebia’s weaker quarterly performance. Next, we’ll examine how the shift to a quarterly loss alongside...
NasdaqGS:JBLU
NasdaqGS:JBLUAirlines

A Look At JetBlue Airways (JBLU) Valuation As Card Refresh And Fort Lauderdale Expansion Advance

Credit card refresh and Fort Lauderdale build out take center stage JetBlue Airways (JBLU) has put its co branded JetBlue Premier World Elite Mastercard and Fort Lauderdale expansion at the heart of its current push to win and retain travelers after Spirit Airlines’ shutdown. The card now offers larger statement credits, status related tile bonuses and a sizable limited time TrueBlue points offer. Fort Lauderdale is set to see new routes, added frequencies and targeted perks for former Spirit...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

Is GitLab (GTLB) Now Attractive After Sharp Share Price Declines This Year?

If you are wondering whether GitLab at around US$25.92 is priced attractively or not, the key is understanding what the current valuation is actually baking in for the future. The stock has recently been volatile, with a 17.1% return over the last 7 days and 12.0% over the last 30 days, yet it still sits on a year to date return of 28.4% decline and a 1 year return of 47.7% decline. Recent coverage has focused on GitLab as a software platform positioned in a competitive developer tools...
NYSE:BIO
NYSE:BIOLife Sciences

A Look At Bio-Rad (BIO) Valuation After Q1 2026 Net Loss And Outlook Cut

Bio-Rad Laboratories (BIO) stock is in focus after Q1 2026 results showed sales of US$592.1 million and a net loss of US$527.1 million, alongside weaker bioprocessing demand and cautious biotech spending. See our latest analysis for Bio-Rad Laboratories. The Q1 2026 net loss and reduced revenue outlook have been followed by a 7 day share price return of 8.14% decline and a year to date share price return of 15.71% decline, while the 1 year total shareholder return of 6.76% suggests longer...
NYSE:MET
NYSE:METInsurance

Is MetLife (MET) Offering Value After Recent 10.7% Share Price Gain?

If you are wondering whether MetLife at around US$78.82 offers fair value or a margin of safety, this article explains what the current price might be indicating. The stock has returned 10.7% over the last 30 days, while the 1-year return is 3.8% and the 3-year return is 67.2%. These figures can influence how investors view both potential upside and risk. Recent coverage has highlighted MetLife's position as a major US insurance company. Investors have been focusing on how interest rate...
NYSE:UGI
NYSE:UGIGas Utilities

Is It Time To Reassess UGI (UGI) After Its Recent Share Price Weakness

If you are wondering whether UGI is attractively priced or just a value trap, starting with the current share price and valuation checks can help frame the picture. UGI closed at US$32.32, with recent returns showing a 10.4% decline over 7 days, 12.7% over 30 days, 14.1% year to date, and 3.6% over 1 year. This is set against a 31.7% gain over 3 years and an 11.3% decline over 5 years. These mixed return figures sit alongside ongoing investor attention on UGI as a regulated utility and...
NasdaqGS:ABNB
NasdaqGS:ABNBHospitality

Airbnb (ABNB) Margin Compression Challenges Bullish Profitability Narratives After FY 2025 Results

Airbnb (ABNB) has wrapped up FY 2025 with fourth quarter revenue of US$2.8b and basic EPS of US$0.56, capping a year where trailing twelve month revenue reached US$12.2b and EPS came in at US$4.10. Over the past few quarters, revenue has moved from US$2.5b in Q4 2024 to US$4.1b in Q3 2025 before landing at US$2.8b in Q4 2025. Over the same stretch, quarterly EPS shifted from US$0.74 to US$2.25 and then to US$0.56, giving investors a clearer view of how profitability tracks Airbnb’s seasonally...
NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Why Advanced Energy Industries (AEIS) Is Down 8.3% After Q1 Beat, Higher Guidance and Capital Moves - And What's Next

Advanced Energy Industries recently reported first-quarter 2026 results showing sales of US$511.0 million and diluted EPS from continuing operations of US$1.58, alongside confirming a US$0.10 quarterly dividend and updating second-quarter guidance. The company also completed a multi‑year share repurchase program, filed new shelf registrations for up to 3.0 million ESOP‑related shares, and signaled an active acquisition pipeline supported by what management describes as a strong balance...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

Assessing LivaNova (LIVN) Valuation After Strong Recent Share Price Momentum

LivaNova overview and recent share moves LivaNova (LIVN) has drawn investor attention after recent share price moves, with the stock showing double digit total returns over the past year, as well as solid gains over the past month and the past three months. See our latest analysis for LivaNova. The recent 7-day share price return of 18.01%, alongside a 16.96% year-to-date share price return and a 60.94% 1-year total shareholder return, indicates that momentum has been building over both...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet (PODD) Is Down 6.8% After Raising 2026 Guidance And Advancing Closed‑Loop Trial - What's Changed

In early May 2026, Insulet Corporation reported that first‑quarter revenue rose to US$761.7 million with net income of US$91.1 million, while also raising its full‑year 2026 GAAP revenue growth guidance to 22%–24% and projecting second‑quarter GAAP revenue growth of 21%–23%. At the same time, Insulet began enrolling participants in its EVOLVE pivotal trial for a fully closed‑loop insulin delivery system for type 2 diabetes, signaling an effort to extend its technology beyond current users...
NasdaqGS:WDC
NasdaqGS:WDCTech

Western Digital Ends Sandisk Link To Sharpen Pure Play AI Storage Story

Western Digital has launched a share swap program allowing investors to exchange Sandisk stock for NasdaqGS:WDC shares. The company plans to exit all remaining Sandisk holdings, completing the unwind of its historic equity link after the Sandisk spinoff. This move simplifies Western Digital's capital structure and removes cross ownership between the two storage businesses. For investors watching NasdaqGS:WDC, this step comes after a period of very strong share price performance. The stock...
NYSE:AWK
NYSE:AWKWater Utilities

Should American Water’s Q1 Earnings, Dividend Hike and Service Investments Require Action From AWK Investors?

In the past quarter, American Water Works Company, Inc. reported first-quarter 2026 sales of US$1,207 million, with net income of US$196 million and basic earnings per share from continuing operations of US$1, while also declaring a quarterly dividend of US$0.895 per share payable on June 2, 2026. Alongside these financial results, the company has been recognized for workplace culture and customer satisfaction and continued to invest in water quality, infrastructure, and community programs...
NYSE:LAZ
NYSE:LAZCapital Markets

Assessing Lazard (LAZ) Valuation After Mixed Q1 2026 Results Weigh On Investor Sentiment

What the mixed Q1 report means for Lazard (LAZ) stock Lazard (LAZ) reported mixed Q1 2026 results, with a strong revenue outcome but adjusted earnings per share below analyst expectations, a combination that helped drive a recent 7.8% drop in the stock. See our latest analysis for Lazard. Over the past year, Lazard’s total shareholder return of 11.2% contrasts with a 6.6% year to date share price decline and a 12.8% 1 month share price gain. This suggests momentum has recently cooled but not...
NasdaqGS:QS
NasdaqGS:QSAuto Components

QuantumScape Starts Eagle Line As Licensing Revenue Story Begins

QuantumScape (NasdaqGS:QS) has started operations at its Eagle Line pilot-scale solid-state battery production facility. The company has recorded its first billings from ecosystem partners, initiating its licensing and royalty revenue stream. These developments represent a shift from pure development work to initial commercialization and monetization of its battery technology. QuantumScape focuses on solid-state lithium-metal batteries aimed at electric vehicles and related applications, a...
NYSE:BIRK
NYSE:BIRKLuxury

Is It Time To Revisit Birkenstock Holding (BIRK) After Recent Share Price Pullback

If you are wondering whether Birkenstock Holding stock is attractively priced or still too expensive for your portfolio, this article breaks down what the current valuation implies. The stock last closed at US$39.04, with recent returns of 0.8% over 7 days, 12.6% over 30 days, and a 6.5% decline year to date, alongside a 25.6% decline over the last year. Recent coverage around Birkenstock Holding has focused on its position in the consumer durables space and how investors are weighing brand...
NasdaqGS:AMPH
NasdaqGS:AMPHPharmaceuticals

Amphastar Pharmaceuticals (AMPH) Margin Compression Reinforces Bearish Narrative Despite Stable Revenue

Amphastar Pharmaceuticals (AMPH) closed out FY 2025 with fourth quarter revenue of US$183.1 million and basic EPS of US$0.53, compared with prior year Q4 revenue of US$186.5 million and EPS of US$0.79, as trailing net profit margin moved from 21.8% to 13.6% over the last 12 months. Over the past six reported quarters, revenue has remained within a relatively narrow range of roughly US$170 million to US$192 million per quarter, while EPS has ranged from US$0.37 to US$0.83, giving investors a...
NYSE:OKLO
NYSE:OKLOElectric Utilities

Did Accelerated NRC Approval of Aurora Design Criteria Just Shift Oklo's (OKLO) Investment Narrative?

In early May 2026, Oklo Inc. reported that the U.S. Nuclear Regulatory Commission approved its Principal Design Criteria topical report for the Aurora powerhouse in Idaho on an accelerated timeline, establishing the core safety, reliability and performance requirements that can be referenced in future licensing applications. This rapid approval materially reduces repetitive regulatory review for Oklo’s advanced reactors and signals that federal modernization efforts are beginning to...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

Cellebrite FedRAMP Win Raises Questions On Undervalued Stock Weak Momentum

Cellebrite DI's Cellebrite Government Cloud platform has received FedRAMP High Authorization, the top federal cloud security standard. The U.S. Department of Justice acted as the sponsoring agency for this authorization. The approval covers handling of highly sensitive unclassified data for federal agencies. Cellebrite DI (NasdaqGS:CLBT) now has its Cellebrite Government Cloud cleared at the FedRAMP High level, placing it among a relatively small group of vendors that meet the federal...
NYSE:FTV
NYSE:FTVMachinery

Is It Too Late To Consider Fortive (FTV) After Its Recent Share Price Climb?

If you are wondering whether Fortive at around US$60.90 is still a fair deal or already pricing in the story, this breakdown will help you size up what you are really paying for the stock. Over the shorter term, Fortive has posted returns of 1.9% over the last week, 7.1% over the last month, 9.9% year to date and 16.3% over the past year, which raises questions about how much of the current valuation is already reflected in the recent share price. Recent attention on Fortive has centered on...
NYSE:BRC
NYSE:BRCCommercial Services

Is It Too Late To Consider Brady (BRC) After Recent Share Price Weakness?

For investors wondering if Brady's current share price still offers value or if most of the opportunity is already priced in, this article walks through what the numbers are really saying about the stock. Brady closed at US$79.53, with a 2.8% decline over the last 7 days and a 1.0% decline over 30 days, while still showing returns of 1.1% year to date and 9.9% over the last year. These price moves sit against a backdrop of ongoing investor interest in Commercial Services companies like Brady...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Is GLOBALFOUNDRIES (GFS) Too Expensive After Recent 97% One-Year Share Price Surge

GLOBALFOUNDRIES stock might already be on your radar, but if you are wondering whether the recent excitement is backed up by value or just momentum, this is where the valuation story starts to take shape. At a last close of US$70.93, the stock shows returns of 9.8% over 7 days, 61.5% over 30 days, 92.4% year to date and 97.4% over the past year. This raises fair questions about how much future upside or downside is already reflected in the price. Recent coverage has focused on GLOBALFOUNDRIES...